The activities of lysyl hydroxylase 3 (LH3) regulate the amount and oligomerization status of adiponectin. 2012

Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
Department of Biochemistry, University of Oulu, Oulu, Finland. heli.ruotsalainen@oulu.fi

Lysyl hydroxylase 3 (LH3) has lysyl hydroxylase, galactosyltransferase, and glucosyltransferase activities, which are sequentially required for the formation of glucosylgalactosyl hydroxylysines in collagens. Here we demonstrate for the first time that LH3 also modifies the lysine residues in the collagenous domain of adiponectin, which has important roles in glucose and lipid metabolism and inflammation. Hydroxylation and, especially, glycosylation of the lysine residues of adiponectin have been shown to be essential for the formation of the more active high molecular weight adiponectin oligomers and thus for its function. In cells that totally lack LH3 enzyme, the galactosylhydroxylysine residues of adiponectin were not glucosylated to glucosylgalactosylhydroxylysine residues and the formation of high and middle molecular weight adiponectin oligomers was impaired. Circulating adiponectin levels in mutant mice lacking the lysyl hydroxylase activity of LH3 were significantly reduced, which indicates that LH3 is required for complete modification of lysine residues in adiponectin and the loss of some of the glycosylated hydroxylysine residues severely affects the secretion of adiponectin. LH mutant mice with reduced adiponectin level showed a high fat diet-induced increase in glucose, triglyceride, and LDL-cholesterol levels, hallmarks of the metabolic syndrome in humans. Our results reveal the first indication that LH3 is an important regulator of adiponectin biosynthesis, secretion and activity and thus might be a potential candidate for therapeutic applications in diseases associated with obesity and insulin resistance.

UI MeSH Term Description Entries
D008239 Lysine An essential amino acid. It is often added to animal feed. Enisyl,L-Lysine,Lysine Acetate,Lysine Hydrochloride,Acetate, Lysine,L Lysine
D008240 Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase A mixed-function oxygenase that catalyzes the hydroxylation of peptidyllysine, usually in protocollagen, to peptidylhydroxylysine. The enzyme utilizes molecular oxygen with concomitant oxidative decarboxylation of the cosubstrate 2-oxoglutarate to succinate. EC 1.14.11.4. Lysine 2-Oxoglutarate Dioxygenase,Lysine Hydroxylase,Protocollagen Lysyl Hydroxylase,Collagen Lysyl Hydroxylase,Lysyl Hydroxylase,2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine,2-Oxoglutarate Dioxygenase, Lysine,5-Dioxygenase Procollagen-Lysine, 2-Oxoglutarate,Dioxygenase, Lysine 2-Oxoglutarate,Hydroxylase, Collagen Lysyl,Hydroxylase, Lysine,Hydroxylase, Lysyl,Hydroxylase, Protocollagen Lysyl,Lysine 2 Oxoglutarate Dioxygenase,Procollagen Lysine, 2 Oxoglutarate 5 Dioxygenase
D008297 Male Males
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009154 Mutation Any detectable and heritable change in the genetic material that causes a change in the GENOTYPE and which is transmitted to daughter cells and to succeeding generations. Mutations
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005260 Female Females

Related Publications

Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
March 2009, Journal of cellular and molecular medicine,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
February 2000, Matrix biology : journal of the International Society for Matrix Biology,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
August 2018, Nature communications,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
January 2011, Matrix biology : journal of the International Society for Matrix Biology,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
September 2018, Nature communications,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
June 2006, Journal of cellular physiology,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
May 2002, The Journal of biological chemistry,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
April 2001, Matrix biology : journal of the International Society for Matrix Biology,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
June 2009, The Journal of investigative dermatology,
Heli Ruotsalainen, and Maija Risteli, and Chunguang Wang, and Yu Wang, and Marjo Karppinen, and Ulrich Bergmann, and Ari-Pekka Kvist, and Helmut Pospiech, and Karl-Heinz Herzig, and Raili Myllylä
May 1998, The Journal of biological chemistry,
Copied contents to your clipboard!